Cabot (CBT) to Announce Quarterly Earnings on Monday

Cabot (NYSE:CBTGet Free Report) is anticipated to post its Q3 2026 results after the market closes on Monday, August 3rd. Analysts expect Cabot to post earnings of $1.66 per share and revenue of $943.1640 million for the quarter. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. Interested persons can find conference call details on the company’s upcoming Q3 2026 earning report for the latest details on the call scheduled for Tuesday, August 4, 2026 at 8:00 AM ET.

Cabot (NYSE:CBTGet Free Report) last announced its quarterly earnings results on Tuesday, May 5th. The specialty chemicals company reported $1.61 EPS for the quarter, beating the consensus estimate of $1.47 by $0.14. The firm had revenue of $904.00 million during the quarter, compared to the consensus estimate of $900.30 million. Cabot had a net margin of 7.97% and a return on equity of 21.33%. The business’s quarterly revenue was down 3.4% compared to the same quarter last year. During the same period last year, the firm earned $1.90 EPS. On average, analysts expect Cabot to post $6 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Cabot Stock Up 0.0%

CBT opened at $90.15 on Monday. The company has a fifty day moving average price of $86.94 and a 200-day moving average price of $78.79. The firm has a market capitalization of $4.65 billion, a P/E ratio of 17.04, a price-to-earnings-growth ratio of 11.73 and a beta of 0.83. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.45 and a quick ratio of 0.96. Cabot has a one year low of $58.33 and a one year high of $94.53.

Cabot Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 11th. Investors of record on Friday, August 28th will be given a $0.4725 dividend. This represents a $1.89 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date is Friday, August 28th. Cabot’s dividend payout ratio (DPR) is 35.73%.

Wall Street Analyst Weigh In

Several research firms recently commented on CBT. UBS Group boosted their target price on Cabot from $81.00 to $86.00 and gave the stock a “neutral” rating in a research report on Friday, May 8th. Truist Financial initiated coverage on Cabot in a research report on Monday, June 8th. They set a “buy” rating and a $98.00 price target for the company. Mizuho boosted their price objective on Cabot from $80.00 to $90.00 and gave the stock a “neutral” rating in a report on Thursday, June 25th. Weiss Ratings restated a “hold (c)” rating on shares of Cabot in a research report on Tuesday, May 26th. Finally, Wall Street Zen raised shares of Cabot from a “hold” rating to a “buy” rating in a research note on Sunday, June 14th. Two research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Cabot has a consensus rating of “Hold” and a consensus price target of $85.80.

Get Our Latest Research Report on Cabot

Institutional Investors Weigh In On Cabot

A number of large investors have recently added to or reduced their stakes in the company. Global Retirement Partners LLC raised its position in Cabot by 1,606.9% during the fourth quarter. Global Retirement Partners LLC now owns 495 shares of the specialty chemicals company’s stock valued at $33,000 after purchasing an additional 466 shares in the last quarter. Danske Bank A S purchased a new position in shares of Cabot in the 3rd quarter worth about $38,000. Geneos Wealth Management Inc. increased its position in shares of Cabot by 409.0% during the 1st quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock valued at $38,000 after purchasing an additional 364 shares during the last quarter. Caitong International Asset Management Co. Ltd raised its holdings in shares of Cabot by 709.1% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 534 shares of the specialty chemicals company’s stock valued at $41,000 after buying an additional 468 shares in the last quarter. Finally, Advisory Services Network LLC purchased a new position in shares of Cabot during the 3rd quarter valued at about $57,000. Hedge funds and other institutional investors own 93.18% of the company’s stock.

Cabot Company Profile

(Get Free Report)

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.

See Also

Earnings History for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.